Parcourir par auteur "Nikolopoulou, V."

Voici les éléments 1-3 de 3

Efficacy of Interferon A-2b Monotherapy in B-Thalassemics with Chronic Hepatitis C

Kalafateli, M.; Kourakli, A.; Gatselis, N.; Lambropoulou, P.; Thomopoulos, K.; Tsamandas, A.; Christofidou, M.; Zachou, K.; Jelastopoulou, E.; Nikolopoulou, V.; Symeonidis, A.; Dalekos, G. N.; Lambropoulou-Karatza, C.; Triantos, C. (2015)

Background & Aims: Monotherapy with standard or pegylated interferon (PegIFN) remains the first-line treatment for HCV infection in patients with thalassemia major (beta TM), although its long-term impact is still unknown. ...
HBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORT

Goulis, L.; Akriviadis, E.; Karatapanis, S.; Deutsch, M.; Dalekos, G. N.; Raptopoulou-Gigi, M. P.; Drakoulis, C.; Mimidis, K.; Germanidis, G.; Nikolopoulou, V.; Chounta, A.; Bakalos, G.; Papatheodoridis, G. V. (2011)
Long term efficacy of Interferon a-2b/Peg-Iinterferon a-2b monotherapy in b-thalassemics with chronic hepatitis C

Triantos, C. K.; Kourakli, A.; Gatselis, N.; Kalafateli, M.; Lambropoulou, P.; De Lastic, A. L.; Thomopoulos, K.; Tsamandas, A.; Christofidou, M.; Jelastopulu, E.; Nikolopoulou, V.; Symeonidis, A.; Dalekos, G. N.; Labropoulou-Karatza, C. C. (2013)